Book Description

In order to reflect recent advances in life sciences, our goal was to have in this meeting a strong representation of the bioorganic and biomedical aspects of phosphorus chemistry, in addition to all the traditional aspects which were represented in the previous ICPC's. We considered that exposing the phosphorus chemists' community to these new frontiers and opportunities for development, will widen horizons and stimulate the conception of new ideas. To achieve this, there was a need to attract scientists who normally do not participate in such a Conference. Thus, we contacted several pharmaceutical companies, medicinal chemists, biochemists and biologists. We succeeded at least partially in this goal, as it is apparent from the various special minisymposia: Biologically active bisphosphonates (7 lectures); Phosphorus related abzymes (8 lectures); Nucleotides (8 lectures); Phospholipids (7 lectures); Biological applications of P-31 NMR spectroscopy (4 lectures); Phosphorus containing NMDA antagonists (6 lectures); Inositol phosphates (7 lectures); Phosphorus containing agrochemicals (6 lectures). In addition to these, there was a general bioorganic-medicinal session (9 lectures) as well as sessions devoted to computational phosphorus chemistry (4 lectures), inorganic phosphorus chemistry (9 lectures), coordination chemistry (26 lectures) and to flame retardants (4 lectures). Still, as in previous ICPC's the major portion of the Conference consisted of contributed presentations in various aspects (synthetic, structural and mechanistic) of organophosphorus chemistry (70 lectures).